AC Immune wins FDA fast track for Alzheimer’s vaccine candidate
AC Immune’s phosphorylated Tau (pTau)-targeting vaccine has secured a fast track designation from the US Food and Drug Administration (FDA) …
AC Immune’s phosphorylated Tau (pTau)-targeting vaccine has secured a fast track designation from the US Food and Drug Administration (FDA) …
Ipsen is looking to expand its paediatric medication portfolio and has signed a licensing agreement potentially worth $461m with Day …
Sandoz has announced the European launch of Pyzchiva, a ustekinumab biosimilar approved for the treatment of several autoimmune conditions including …
The US Food and Drug Administration (FDA) has granted ConSynance Therapeutics a rare paediatric disease designation for its oral therapy …
The US Food and Drug Administration (FDA) has expanded its approval of BioMarin Pharmaceutical's supplemental biologics licence application (sBLA) for …
The US Food and Drug Administration (FDA) has granted ConSynance Therapeutics a rare paediatric disease designation for its oral therapy …
The US Food and Drug Administration (FDA) has expanded its approval of BioMarin Pharmaceutical's supplemental biologics licence application (sBLA) for …
The UK National Institute for Health and Care Excellence (NICE) has issued final guidance endorsing Boehringer Ingelheim’s tenecteplase, marketed as …
Dren Bio has partnered strategically with Novartis subsidiary Novartis Pharma to discover and develop therapeutic bispecific antibodies to treat cancer. The …
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer-BioNTech’s adapted Comirnaty vaccine to combat …
BioAtla has received a fast track designation from the US Food and Drug Administration (FDA) for its antibody drug conjugate …
3D printing, also known as additive manufacturing (AM), is the process of joining materials to make objects from three-dimensional model …
A day after announcing a $400m convertible bond offering, Telix Pharmaceuticals has had a new drug application (NDA) accepted by …
The US Food and Drug Administration (FDA)-mandated monitoring time for CAR-T therapy patients could be halved, according to a new …
AstraZeneca has signed a licensing agreement with Pinetree Therapeutics for a preclinical epidermal growth factor receptor (EGFR) degrader candidate, potentially …